What is Nova Pharma Solutions Bhd Earnings Yield (Joel Greenblatt) %?
Nova Pharma Solutions Bhd's Enterprise Value for the quarter that ended in Dec. 2023 was RM20.85 Mil.
Nova Pharma Solutions Bhd's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was RM4.92 Mil. Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 23.58%.
The historical rank and industry rank for Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XKLS:03006'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3.96 Med: 4.39 Max: 23.58
Current: 18.94
During the past 9 years, the highest Earnings Yield (Joel Greenblatt) of Nova Pharma Solutions Bhd was 23.58%. The lowest was -3.96%. And the median was 4.39%.
XKLS:03006's Earnings Yield (Joel Greenblatt) % is not ranked
in the Construction industry.
Industry Median: 6.45
vs XKLS:03006: 18.94
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Nova Pharma Solutions Bhd's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Nova Pharma Solutions Bhd Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Nova Pharma Solutions Bhd Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) %
For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % Distribution in the Construction Industry
For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % falls into.
Nova Pharma Solutions Bhd Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Nova Pharma Solutions Bhds Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
Nova Pharma Solutions Bhd (XKLS:03006) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Nova Pharma Solutions Bhd Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nova Pharma Solutions Bhd (XKLS:03006) Business Description
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:03006 has been successfully added to your 